US appeal denied in Czech blood plasma saga
A Liechtenstein company has failed in its latest bid to enforce a US$400 million award against the Czech Republic in the US courts, as its founder pursues a related investment treaty claim worth US$2.5 billion.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.